Claudia Greißing1, Peter Buchal, Hans-Joachim Kabitz, Marcus Schuchmann, Niko Zantl, Susanne Schiek, Thilo Bertsche. 1. Pharmacy Department, Konstanz Hospital; Drug Safety Center, Leipzig University and University Hospital of Leipzig, Department of Clinical Pharmacy, Institute of Pharmacy, Leipzig University; Konstanz Hospital, Medical Clinic II; Konstanz Hospital, Medical Clinic I; Singen Hospital, Department of Urology and Pediatric Urology.
Abstract
BACKGROUND: Patients' drug regimens often need to be changed when they pass from one care sector to another, but these changes sometimes pose a safety risk. To avoid such risks, a new inter-sector transition concept was developed incorporating discharge medication plans and counseling modules for the patients themselves and the doctors receiving them into their care. METHODS: A prospective interventional trial was carried out in two internal medicine wards of a general hospital. After data acquisition from the control group, the transition concept was developed and evaluated in an independent intervention group. The discharge medication plan and the first post-discharge prescription were compared to identify patients who had at least one medication change that increased the post-discharge risk of either failure to achieve the therapeutic goal (category A, first endpoint) or of patient's lack of treatment adherence (category B). Gaps in care after discharge were also analyzed. RESULTS:200 consecutive patients were enrolled in the trial. In the intention-to-treat analysis, the percentage of patients with potentially jeopardizing medication changes in category A declined from 54% (54/100) in the control group to 15% (15/100) in the intervention group. (p<0.001). For medication changes in category B, there was a corresponding decline from 53% (53/100) to 7% (7/100) (p < 0.001). Gaps in care were seen in 28% (28/100) of control patients and 18% (18/100) of patients in the intervention group (p = 0.031). CONCLUSION: The likelihood of a potentially jeopardizing medication change upon hospital discharge can be markedly reduced with the aid of a modular transition concept. Gaps in care can be closed in this way as well.
RCT Entities:
BACKGROUND:Patients' drug regimens often need to be changed when they pass from one care sector to another, but these changes sometimes pose a safety risk. To avoid such risks, a new inter-sector transition concept was developed incorporating discharge medication plans and counseling modules for the patients themselves and the doctors receiving them into their care. METHODS: A prospective interventional trial was carried out in two internal medicine wards of a general hospital. After data acquisition from the control group, the transition concept was developed and evaluated in an independent intervention group. The discharge medication plan and the first post-discharge prescription were compared to identify patients who had at least one medication change that increased the post-discharge risk of either failure to achieve the therapeutic goal (category A, first endpoint) or of patient's lack of treatment adherence (category B). Gaps in care after discharge were also analyzed. RESULTS: 200 consecutive patients were enrolled in the trial. In the intention-to-treat analysis, the percentage of patients with potentially jeopardizing medication changes in category A declined from 54% (54/100) in the control group to 15% (15/100) in the intervention group. (p<0.001). For medication changes in category B, there was a corresponding decline from 53% (53/100) to 7% (7/100) (p < 0.001). Gaps in care were seen in 28% (28/100) of control patients and 18% (18/100) of patients in the intervention group (p = 0.031). CONCLUSION: The likelihood of a potentially jeopardizing medication change upon hospital discharge can be markedly reduced with the aid of a modular transition concept. Gaps in care can be closed in this way as well.
Authors: Jeffrey L Greenwald; Lakshmi K Halasyamani; Jan Greene; Cynthia LaCivita; Erin Stucky; Bona Benjamin; William Reid; Frances A Griffin; Allen J Vaida; Mark V Williams Journal: Jt Comm J Qual Patient Saf Date: 2010-11
Authors: Vincent C Tam; Sandra R Knowles; Patricia L Cornish; Nowell Fine; Romina Marchesano; Edward E Etchells Journal: CMAJ Date: 2005-08-30 Impact factor: 8.262
Authors: Lee A Lindquist; Lise Go; Jori Fleisher; Nelia Jain; Elisha Friesema; David W Baker Journal: J Gen Intern Med Date: 2011-10-05 Impact factor: 5.128
Authors: C Mahler; S Jank; M G Pruszydlo; K Hermann; H Gärtner; J Kaltschmidt; S Ludt; T Bertsche; W E Haefeli; J Szecsenyi Journal: Dtsch Med Wochenschr Date: 2011-10-25 Impact factor: 0.628
Authors: Jennifer R Pippins; Tejal K Gandhi; Claus Hamann; Chima D Ndumele; Stephanie A Labonville; Ellen K Diedrichsen; Marcy G Carty; Andrew S Karson; Ishir Bhan; Christopher M Coley; Catherine L Liang; Alexander Turchin; Patricia C McCarthy; Jeffrey L Schnipper Journal: J Gen Intern Med Date: 2008-06-19 Impact factor: 5.128
Authors: Nikoletta Zeschick; Julia Gollnick; Julia Muth; Franziska Hörbrand; Peter Killian; Wolfgang Krombholz; Norbert Donner-Banzhoff; Thomas Kühlein; Maria Sebastião Journal: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Date: 2022-07-15 Impact factor: 1.595